(1S,2S)-2-Methylcyclopropanamine hydrochloride, 95%, 500mg

5-BROMO-4-(TRIFLUOROMETHYL)-1-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-1H-IMIDAZOLE, 95.0%, 250mg

2H-Pyrido[4,3-b][1,4]oxazin-3(4H)-one, 95.0%, 250mg

4-Methyl-oxazole-5-carboxylic acid amide, 250mg

4'-Chlorophenyl acetylene, 98.0%, 500g

4-Chloro-6-(1H-pyrazol-1-yl)pyrimidin-5-amine, 97%, 100mg

Lithium chloride, min. 99%, pa, ACS, 100 g, plastic packaging.

Cyclopentanecarboxamide, 95.0%, 5g

Methyl (R)-2-(chloromethyl)-1-(oxetan-2-ylmethyl)-1H-benzo[d]imidazole-6-carboxylate, 98%, 500mg

2-(Diphenylphosphanyl)benzenesulfonic acid, 97%, 1g

(E)-3-(2-Nitrovinyl)furan, 1g

(2-Fluoro-3-methoxy-4-(trifluoromethyl)phenyl)(methyl)sulfane, 98%, 5g

Dimethyl 4-aminophthalate, 95.0%, 250mg